hers still selling semaglutide Hims and likely to stop cheaper versions of GLP-1 medications Hims & Hers warns it

Results Table 21 presents the Week 72 histopathology primary endpoint results comparing WEGOVY injection with placebo on: 1) the estimated percentage of patients with resolution of steatohepatitis and no worsening of liver fibrosis and 2) the estimated percentage of patients with at least one stage improvement in liver fibrosis and no worsening of steatohepatitis

These exorbitant costs have made it extremely challenging to be able to continue to provide drug coverage to everyone who wants these drugs but does not have an FDA-approved medical or indication for these drugs, the company stated

Take the dose, then continue weekly on the new day from that point on

BEL 2 Recommendation 15.3 Hospitalized persons with hyperglycemia but without known DM should have A1C measured to identify preexisting DM and inform discharge planning